These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 423087)

  • 1. New in vitro dissolution test apparatus.
    Nasir SS; Wilken LO; Nasir SM
    J Pharm Sci; 1979 Feb; 68(2):177-81. PubMed ID: 423087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of aspirin excretion with parameters from different dissolution methods.
    Needham TE; Shah K; Kotzan J; Zia H
    J Pharm Sci; 1978 Aug; 67(8):1070-3. PubMed ID: 671239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic error associated with apparatus 2 of the USP dissolution test IV: effect of air dissolved in the dissolution medium.
    Cox DC; Furman WB; Page DP
    J Pharm Sci; 1983 Sep; 72(9):1061-4. PubMed ID: 6631694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of in vitro test conditions on release of aspirin from commercial tablets.
    Nikolić L; Djurić Z; Jovanović M
    J Pharm Sci; 1992 Apr; 81(4):386-91. PubMed ID: 1501078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of prednisone tablets in the presence of an arch-shaped fiber optic probe in a USP dissolution testing apparatus 2.
    Zhang Y; Bredael G; Armenante PM
    J Pharm Sci; 2013 Aug; 102(8):2718-29. PubMed ID: 23861178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The science of USP 1 and 2 dissolution: present challenges and future relevance.
    Gray V; Kelly G; Xia M; Butler C; Thomas S; Mayock S
    Pharm Res; 2009 Jun; 26(6):1289-302. PubMed ID: 19165579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
    Koch HP; Pfeifer G
    Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic error associated with apparatus 2 of the USP dissolution test III: limitations of calibrators and the USP suitability test.
    Cox DC; Furman WB; Thornton LK; Moore TW; Jefferson EH
    J Pharm Sci; 1983 Aug; 72(8):910-3. PubMed ID: 6620145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation on the USP-NF rotating-basket dissolution apparatus and a new device for dissolution rate studies of solid dosage forms.
    Haringer G; Poulsen BJ; Havemeyer RN
    J Pharm Sci; 1973 Jan; 62(1):130-2. PubMed ID: 4682913
    [No Abstract]   [Full Text] [Related]  

  • 12. Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets.
    Savage TS; Wells CE
    J Pharm Sci; 1982 Jun; 71(6):670-3. PubMed ID: 7097531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Dissolution Method for Gliclazide Modified-Release Tablets Using USP Apparatus 3 with in Vitro-in Vivo Correlation.
    Bezerra KC; Pinto EC; Cabral LM; de Sousa VP
    Chem Pharm Bull (Tokyo); 2018; 66(7):701-707. PubMed ID: 29962453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
    Cox DC; Furman WB
    J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
    [No Abstract]   [Full Text] [Related]  

  • 15. New Approach for the Application of USP Apparatus 3 in Dissolution Tests: Case Studies of Three Antihypertensive Immediate-Release Tablets.
    Espíndola B; Bortolon FF; Pinto JMO; Pezzini BR; Stulzer HK
    AAPS PharmSciTech; 2018 Oct; 19(7):2866-2874. PubMed ID: 29934804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two dissolution apparatuses with correlation of in vitro-in vivo data for prednisone and prednisolone tablets.
    Milsap RL; Ayres JW; Mackichan JJ; Wagner JG
    Biopharm Drug Dispos; 1979; 1(1):3-17. PubMed ID: 552859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
    Cox DC; Wells CE; Furman WB; Savage TS; King AC
    J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative study of the USP dissolution test for prednisone tablets with Apparatus 2.
    Cox DC; Furman WB
    J Pharm Sci; 1984 May; 73(5):670-6. PubMed ID: 6737242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized automated system for determining dissolution rate profiles for solid dosage forms.
    Cioffi FJ; Abdou HM; Warren AT
    J Pharm Sci; 1976 Aug; 65(8):1234-40. PubMed ID: 978444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.